Identifying cancer drug regimens in French health insurance database: An application in multiple myeloma patients.
Aurore PalmaroMartin GauthierFabien DespasMaryse Lapeyre MestrePublished in: Pharmacoepidemiology and drug safety (2017)
This study demonstrates the feasibility of identifying complex drug regimens in onco-haematology, using both outpatient and inpatient drug records in French health insurance databases.
Keyphrases
- health insurance
- affordable care act
- adverse drug
- end stage renal disease
- multiple myeloma
- ejection fraction
- newly diagnosed
- chronic kidney disease
- papillary thyroid
- prognostic factors
- mental health
- drug induced
- healthcare
- emergency department
- squamous cell
- deep learning
- machine learning
- young adults
- patient reported outcomes
- patient reported
- artificial intelligence